Showing results (921-930 of 938) with videos related to
Sort By:
Pageof 94
Plos One|August 29, 2015
Encapsulated Brucella ovis Lacking a Putative ATP-Binding Cassette Transporter (ΔabcBA) Protects against Wild Type Brucella ovis in RamsAna Patrícia C Silva, Auricélio A Macêdo, Luciana F Costa, et al.The Journal of Infectious Diseases|October 5, 2013
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observationAnne Szarewski, S Rachel Skinner, Suzanne M Garland, et al.The Journal of Infectious Diseases|March 11, 2014
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIAXavier Castellsagué, Paulo Naud, Song-Nan Chow, et al.Plos One|November 22, 2013
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA studyUnnop Jaisamrarn, Xavier Castellsagué, Suzanne M Garland, et al.The Lancet. Oncology|November 15, 2011
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trialMatti Lehtinen, Jorma Paavonen, Cosette M Wheeler, et al.Clinical and Vaccine Immunology : CVI|December 26, 2014
Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNAFrank Struyf, Brigitte Colau, Cosette M Wheeler, et al.Journal of Thrombosis and Thrombolysis|May 18, 2026
External validation of established clinical risk scores for cancer-associated venous thromboembolism in a Brazilian registryMárcia Fayad Marcondes de Abreu, Mohamad Al Bannoud, Sandra Martins, et al.Frontiers in Immunology|June 9, 2023
Tumor-neutrophil crosstalk promotes Dominique S Rubenich, Priscila O de Souza, Natalia Omizzollo, et al.Lancet (London, England)|December 8, 2009
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years, B Romanowski, P Colares de Borba, et al.Clinical Drug Investigation|May 31, 2007
One year of Lamivudine therapy for portuguese patients with chronic hepatitis BJ Areias, F Calinas, A Porto, et al.Pageof 94